In recent months, we've witnessed a shocking wave of data breaches that have put the personal information of millions at risk. With our online lives becoming more exposed than ever, it's essential to ...

You can’t scroll through a financial news feed today without seeing a headline about a major market segment, be it tech or industrials, getting completely reshaped by artificial intelligence. If ...

Adagrasib and pembrolizumab combination therapy achieved a median PFS of 27.7 months in KRASG12C-mutated NSCLC patients with PD-L1 ≥50%. The combination therapy showed a 59.3% overall response rate, ...